This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Tria Bioscience Corp.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Keith D Miller: Innovator in Vaccine Delivery Systems
Introduction
Keith D Miller is a notable inventor based in Moscow, ID (US). He has made significant contributions to the field of vaccine delivery systems through his innovative research and development.
Latest Patents
Miller holds a patent for "Synthetic hapten carrier compositions and methods." This patent involves peptide monomers that comprise an amphipathic α-helical peptide, and optionally, at least one T cell epitope peptide. The invention also includes dimers and trimers made from these peptide monomers. These peptide conjugates are designed to be linked to a hapten, which is connected to a lysine or aspartic acid residue of the peptide monomer. The resulting peptide conjugates serve as effective vaccine delivery vehicles. He has 1 patent to his name.
Career Highlights
Miller is associated with Tria Bioscience Corp., where he continues to advance his research in the field of immunology and vaccine development. His work focuses on creating innovative solutions that enhance the efficacy of vaccines.
Collaborations
One of his notable coworkers is Christopher H Clegg, with whom he collaborates on various projects related to vaccine technology.
Conclusion
Keith D Miller's contributions to vaccine delivery systems highlight his role as an innovator in the field. His patent for synthetic hapten carrier compositions showcases his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile